Chief Medical Officer
Biotia Inc.
Disclosure: Biotia (Employee)
Dorottya Nagy-Szakal, MD, PhD, Chief Medical Officer, with 15+ years of experience in infectious diseases, AI-powered molecular diagnostics and translational medicine.
My career spans a range of areas from running successful clinical trials and building and overseeing clinical diagnostic laboratories to holding technical and practical workshops as well as invited talks at major international congresses. My industry expertise is deep rooted in academic and translational research with 30+ peer reviewed publications (in JAMA, Nature Communications, Scientific Reports, Cell and MBio) and over 50 international presentations spanning the fields of Microbiome, Pediatric Gastroenterology, Neuroscience, Clinical Microbiology, Infectious Diseases as well as Public Health.
At my current position as the Chief Medical Officer at Biotia and a Research Assistant Professor at SUNY Downstate, I am responsible to implement novel technologies at the laboratory, to achieve the highest quality of research by state standards, to provide clinical implementation of microbiome and virome data, and to engage healthcare leaders using our novel AI-driven technology in infectious disease diagnostics. During the COVID-19 pandemic, I was able to achieve provisional New York State CLIA approval for the Biotia laboratory for SARS-CoV-2 variant testing and to validate and implement novel NGS diagnostics highlighting the importance of precision infectious disease diagostics, genomic epidemiology and antimicrobial stewardship. At Biotia, I drive strategic communications with the FDA, CDC, NYS DOH, enterprise medical centers and responsible for the clinical operations, medical affairs and clinical/R&D laboratory operations.
I completed postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University; and earned my MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary.
